Two-year Outcomes in Female Patients From a Prospective Randomized Trial of Humacyte’s Acellular Tissue Engineered Vessel vs Autologous Arteriovenous Fistula for Hemodialysis
Journal of Vascular Surgery · 2026-05 · 83 (5) · S19
DOI: 10.1016/j.jvs.2025.12.199 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Vascular Surgery, 2026-05. Verfasst von Mohamad A. Hussain und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hussain, M. A., Bou-Ghannam, S., Bates, R., Khondker, Z., Berdugo, M., Parikh, S., & Niklason, L. (2026). Two-year Outcomes in Female Patients From a Prospective Randomized Trial of Humacyte’s Acellular Tissue Engineered Vessel vs Autologous Arteriovenous Fistula for Hemodialysis. Journal of Vascular Surgery, 83(5), S19. https://doi.org/10.1016/j.jvs.2025.12.199
Vancouver
Hussain MA, Bou-Ghannam S, Bates R, Khondker Z, Berdugo M, Parikh S, et al. Two-year Outcomes in Female Patients From a Prospective Randomized Trial of Humacyte’s Acellular Tissue Engineered Vessel vs Autologous Arteriovenous Fistula for Hemodialysis. Journal of Vascular Surgery. 2026;83(5):S19. doi:10.1016/j.jvs.2025.12.199
BibTeX
@article{Hussain2026,
author = {Hussain, Mohamad A. and Bou-Ghannam, Sophia and Bates, Rebecca and Khondker, Zak and Berdugo, Mauricio and Parikh, Shamik and Niklason, Laura},
title = {Two-year Outcomes in Female Patients From a Prospective Randomized Trial of Humacyte’s Acellular Tissue Engineered Vessel vs Autologous Arteriovenous Fistula for Hemodialysis},
journal = {Journal of Vascular Surgery},
year = {2026},
volume = {83},
number = {5},
pages = {S19},
doi = {10.1016/j.jvs.2025.12.199}
}
EUVIMED